Immunome (NASDAQ:IMNM – Get Free Report) had its price target dropped by stock analysts at Guggenheim from $35.00 to $25.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback